Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pfizer Inc. shares valued at $227,603 were sold by DAMICO JENNIFER B. on Jun 07. At $53.96 per share, DAMICO JENNIFER B. sold 4,218 shares. The insider’s holdings dropped to 10,846 shares worth approximately $0.48 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, DAMICO JENNIFER B. sold 4,000 shares, netting a total of over 202,000 in proceeds. Following the sale of shares at $50.50 each, the insider now holds 15,064 shares.
Before that, SAHNI PAYAL had sold 1,408 shares from its account. In a trade valued at $70,175, the Executive Vice President traded Pfizer Inc. shares for $49.84 each. Upon closing the transaction, the insider’s holdings decreased to 1,408 shares, worth approximately $0.77 million.
As published in their initiating research note from SVB Leerink on May 23, 2022, Pfizer Inc. [PFE] has been a Mkt perform and the price target has been revised to $55. This represents a 18.96% premium over Thursday’s closing price. As of January 05, 2022, BofA Securities has increased its “Neutral” rating to a “Buy” for PFE. Earlier on January 03, 2022, Bernstein resumed its rating. Their recommendation was “a Mkt perform” for PFE stock.
Analyzing PFE’s Price Performance
On Thursday, Pfizer Inc. [NYSE: PFE] rose 1.48% to $44.57. The stock’s lowest price that day was $43.52, but it reached a high of $45.00 in the same session. During the last five days, there has been a drop of approximately -2.98%. Over the course of the year, Pfizer Inc. shares have dropped approximately -24.52%. Shares of the company reached a 52-week high of $58.55 on 01/03/22 and a 52-week low of $43.52 on 09/22/22. A 50-day SMA is recorded $48.51, while a 200-day SMA reached $51.25. Nevertheless, trading volume fell to 18.48 million shares from 17.51 million shares the previous day.
Support And Resistance Levels for Pfizer Inc. (PFE)
According to the 24-hour chart, there is a support level at 43.73, which, if violated, would cause prices to drop to 42.88. In the upper region, resistance lies at 45.21. The next price resistance is at 45.84. RSI (Relative Strength Index) is 36.16 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.53, which suggests the price will decrease in the coming days. Percent R is at 78.26%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Pfizer Inc. subject to short interest?
Stocks of Pfizer Inc. saw a sharp rise in short interest on Aug 30, 2022 jumping by 2.3 million shares to 62.2 million. Data from Yahoo Finance shows that the short interest on Jul 28, 2022 was 59.9 million shares. A jump of 3.7% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.47 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.47.
Which companies own the most shares of Pfizer Inc. (PFE)?
According to The Vanguard Group, Inc. filings, the company currently owns 465,062,213 shares, which is about 8.29% of the total PFE shares outstanding. The investor’s shares have appreciated by 8,672,730 from its previous 13-F filing of 456389483.0 shares. With the completion of the buy transaction, SSgA Funds Management, Inc.’s stake is now worth $12,990,826,176. BlackRock Fund Advisors acquire a 7.31% interest valued at $12.86 billion while Capital Research & Management Co purchased a 30,250,912 stake. A total of 2,497,346 shares of Pfizer Inc. were bought by Wellington Management Co. LLP during the quarter, and 3,684,436 were bought by Geode Capital Management LLC. In its current portfolio, Northern Trust Investments, Inc. holds 66,978,348 shares valued at $3.03 billion.
In terms of Pfizer Inc. share price expectations, FactSet research, analysts set an average price target of $55.88 in the next 12 months, up nearly 20.67% from the previous closing price of $43.92. Analysts anticipate Pfizer Inc. stock to reach $75.00 by 2022, with the lowest price target being $44.00. In spite of this, 23 analysts ranked Pfizer Inc. stock as an Overweight at the end of 2022. On December 20, 2021, Cowen assigned a price target of “an Outperform” to the stock and reiterated coverage with a $70.